LENETIX^® Medical Screening Laboratory Receives California Genetic Testing Permit

Business Wire
2007

LENETIX^® Medical Screening Laboratory, Inc. today announced at the 55th Annual American College of Obstetricians and Gynecologists (ACOG) Meeting that it has been granted a clinical laboratory permit by the State of California. LENETIX^® Medical Screening Laboratory is a New York-based provider of rapid genetic risk assessment tools and diagnostic tests for clinicians worldwide, and is a key partner of Sequenom Inc. (NASDAQ: SQNM), a San Diego-based company that is developing a portfolio of non-invasive prenatal diagnostics. The notification means that LENETIX^® is now permitted to receive clinical samples from clients residing in California.

 "The opportunity that this permit brings to Lenetix is immeasurable," said Leonard Kellner, President of LENETIX^® . "Establishing a presence in California will allow us to build a strong customer base in anticipation of establishing a full-service genetics laboratory serving our clients on the West Coast. Our goal is to open a facility in California."

 "We are very pleased that LENETIX^® has been granted this permit to expand its business operations to include the state of California," said Harry Stylli, Ph.D., President and Chief Executive Officer of Sequenom. "The granting of this permit provides the potential for Lenetix to geographically expand its market reach with Sequenom's prenatal diagnostic technology. LENETIX^® is our first clinical licensee and is scheduled to launch its 'home brew' application for non-invasive prenatal testing for RHD incompatibility this year."

About LENETIX^®
Founded in 2001, Mineola, NY-based LENETIX^® is a privately owned provider of innovative technologies focused on diagnostic testing, including prenatal diagnostics, and risk assessment for genetic disease. LENETIX^® brings more than 27 years' experience developing new and innovative tests that are used by clinicians worldwide. The scientific team at LENETIX^® is well known for its ability to commercialize new technologies. It is recognized for its translational clinical research and integration of high quality clinical laboratory genetics services within medical centers, universities, and the private sector.

Contact :
 LENETIX® Medical Screening Laboratory, Inc.
Leonard Kellner, President,
516-248-0036 www.lenetix.com